Site-Specific RNase A Activity Was Dramatically Reduced in Serum from Multiple Types of Cancer Patients

• Weiyan Huang,

  Affiliation Institute of Molecular Medicine, Peking University, Beijing, People’s Republic of China

  ⨯
• Mei Zhao,

  Affiliation Department of Etiology and Carcinogenesis and State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China

  ⨯
• Na Wei,

  Affiliation Institute of Molecular Medicine, Peking University, Beijing, People’s Republic of China

  ⨯
• Xiaoxia Wang,

  Affiliation Institute of Molecular Medicine, Peking University, Beijing, People’s Republic of China

  ⨯
• Huqing Cao,

  Affiliation Institute of Molecular Medicine, Peking University, Beijing, People’s Republic of China

  ⨯
• Quan Du ,

  * E-mail: quan.du@pku.edu.cn (QD); liangz@pku.edu.cn (ZL)

  Affiliation Institute of Molecular Medicine, and the State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, People’s Republic of China

  ⨯
• Zicai Liang

  * E-mail: quan.du@pku.edu.cn (QD); liangz@pku.edu.cn (ZL)

  Affiliation Institute of Molecular Medicine, Peking University, Beijing, People’s Republic of China

  ⨯